India  
NewsR.in
> >

Study renders insights into genetic abnormalities leading to multiple myeloma

Mid-Day Tuesday, 13 March 2018
Study renders insights into genetic abnormalities leading to multiple myelomaIn India, incidence of multiple myeloma affects 1.8 per cent in a population of 100,000. Approximately, 50,000 new cases of multiple myeloma are diagnosed each year. A recent study conducted by CORE Diagnostics reveal that genetic abnormalities are more prevalent among younger median age of 50 years to 70 years, which forms 65...
0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this


Other recent news in India

Jammu and Kashmir: Militant killed in encounter with security forces in BANDIPORA districtTwo militants killed in Jammu and KASHMIR's Bandipora after search operation turned into encounter
No politics, only patriotism: Prakash Javadekar says SURGICAL STRIKE DAY circular just a 'suggestion'JET AIRWAYS horror: Suresh Prabhu orders safety audit of all airlines, airports

Recent related videos

Cincinnati plays role in breakthrough multiple sclerosis study [Video]Cincinnati plays role in breakthrough multiple sclerosis study

UC Health played a big part in a study that resulted in a breakthrough in treatment for progressive multiple sclerosis.

WCPO Cincinnati -   01:36

PA Live: MULTIPLE MYELOMA-September 19, 2016 [Video]PA Live: MULTIPLE MYELOMA-September 19, 2016

THERE ARE SEVERAL DIFFERENT TYPES OF BLOOD CANCER, AND WHILE SOME CAN BE CURABLE, OTHERS LIKE MULTIPLE MYELOMA ARE NOT. DR. KENNETH SHAIN MOFFITT CANCER CENTER, TAMPA, FL JOINS US NOW WITH THE DETAILS..

WBRE -  

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter